Executive Summary
Papoutsanis S.A. produces and sells body, face, and hair care products in Greece and internationally.
Snowflake
Fundamentals
Proven track record with mediocre balance sheet.
Risks
- Papoutsanis is not covered by any analysts.
Share Price & News
How has Papoutsanis's share price performed over time and what events caused price changes?
Latest Share Price and Events
Market Performance
7 Day Return
9.7%
ATSE:PAP
1.2%
GR Personal Products
4.6%
GR Market
1 Year Return
103.6%
ATSE:PAP
10.3%
GR Personal Products
8.2%
GR Market
PAP outperformed the Personal Products industry which returned 10.3% over the past year.
PAP outperformed the Market in Greece which returned 8.2% over the past year.
Share holder returns
| PAP | Industry | Market | |
|---|---|---|---|
| 7 Day | 9.7% | 1.2% | 4.6% |
| 30 Day | -7.6% | -0.8% | -5.6% |
| 90 Day | 19.2% | -1.2% | 12.3% |
| 1 Year | 108.8%103.6% | 12.9%10.3% | 11.6%8.2% |
| 3 Year | 608.9%591.2% | 42.7%33.1% | 56.5%42.5% |
| 5 Year | 69.7%65.5% | 97.6%76.1% | -80.2%-80.8% |
Price Volatility Vs. Market
How volatile is Papoutsanis's share price compared to the market and industry in the last 5 years?
Simply Wall St News
5 days ago | Simply Wall St
A Look At The Fair Value Of Papoutsanis S.A. (ATH:PAP)3 weeks ago | Simply Wall St
Papoutsanis S.A. (ATH:PAP) Might Not Be A Great Investment1 month ago | Simply Wall St
Is Papoutsanis (ATH:PAP) A Risky Investment?Valuation
Is Papoutsanis undervalued based on future cash flows and its price relative to the stock market?
17%
Discount to future cash flow value
Intrinsic Value Based on Future Cash Flows
Papoutsanis's share price is below the future cash flow value, but not at a moderate discount (< 20%).
Papoutsanis's share price is below the future cash flow value, but not at a substantial discount (< 40%).
Price Based on Earnings
Papoutsanis is overvalued based on earnings compared to the Europe Personal Products industry average.
Papoutsanis is overvalued based on earnings compared to the Greece market.
Price Based on Expected Growth
Unable to calculate PEG ratio for Papoutsanis, we can't assess if its growth is good value.
Price Based on Value of Assets
Papoutsanis is overvalued based on assets compared to the Europe Personal Products industry average.
Next Steps
Future Growth
How is Papoutsanis expected to perform in the next 1 to 3 years based on estimates from 0 analysts?
7.1%
Forecasted Household industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Papoutsanis has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Next Steps
- Check out Papoutsanis's track record over time to understand how much the company has returned to shareholders and its earnings growth rate in the past.
- Papoutsanis competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Household industry.
Past Performance
How has Papoutsanis performed over the past 5 years?
63.9%
Historical annual earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
Papoutsanis has delivered over 20% year on year earnings growth in the past 5 years.
Papoutsanis's 1-year earnings growth exceeds its 5-year average (162.9% vs 63.9%)
Papoutsanis's earnings growth has exceeded the Europe Personal Products industry average in the past year (162.9% vs 3.6%).
Return on Equity
Papoutsanis has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
Return on Assets
Papoutsanis used its assets less efficiently than the Europe Personal Products industry average last year based on Return on Assets.
Return on Capital Employed
Papoutsanis has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
Next Steps
Financial Health
How is Papoutsanis's financial position?
Financial Position Analysis
Papoutsanis is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Papoutsanis's cash and other short term assets cover its long term commitments.
Debt to Equity History and Analysis
Papoutsanis's level of debt (43.4%) compared to net worth is high (greater than 40%).
The level of debt compared to net worth has increased over the past 5 years (38.3% vs 43.4% today).
Debt is well covered by operating cash flow (45.7%, greater than 20% of total debt).
Interest payments on debt are not well covered by earnings (EBIT is 2.9x annual interest expense, ideally 3x coverage).
Balance Sheet
High level of physical assets or inventory.
Debt is covered by short term assets, assets are 1.5x debt.
Next Steps
Dividend
What is Papoutsanis's current dividend yield, its reliability and sustainability?
Dividend Yield and Payments Analysis
Unable to evaluate Papoutsanis's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
Unable to evaluate Papoutsanis's dividend against the top 25% market benchmark as the company has not reported any payouts.
Unable to perform a dividend volatility check as Papoutsanis has not reported any payouts.
Unable to verify if Papoutsanis's dividend has been increasing as the company has not reported any payouts.
Current Payout to Shareholders
Unable to calculate sustainability of dividends as Papoutsanis has not reported any payouts.
Future Payout to Shareholders
Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
Next Steps
Management
What is the CEO of Papoutsanis's salary, the management and board of directors tenure and is there insider trading?
9.2yrs
Average board tenure
CEO
Papoutsanis has no CEO, or we have no data on them.
Board Age and Tenure
9.2yrs
Average Tenure
The tenure for the Papoutsanis board of directors is about average.
Insider Trading
No 3 month open market individual insider trading information.
Ownership Breakdown
Management Team
Georgios Gkatzaros
Executive Chairman
- Tenure: 9.2yrs
Mary Iskalatian
CFO, Finance Director & Executive Director
- Tenure: 0.0yrs
Alexandros Georgiadis
Head of Accounting Department
- Tenure: 0.0yrs
Board Members
Georgios Gkatzaros
Executive Chairman
- Tenure: 9.2yrs
Menelaos Tasopoulos
Executive Vice-Chairman
- Tenure: 9.2yrs
George Minoudis
Non-Executive Director
- Tenure: 9.2yrs
Dimitrios Papoutsanis
Independent Non-Executive Director
- Tenure: 9.2yrs
Christos Georgalis
Independent Non-Executive Director
- Tenure: 0.0yrs
Mary Iskalatian
CFO, Finance Director & Executive Director
- Tenure: 0.0yrs
Company Information
Papoutsanis S.A.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: Papoutsanis S.A.
- Ticker: PAP
- Exchange: ATSE
- Founded: 1870
- Industry: Personal Products
- Sector: Household
- Market Cap: €41.320m
- Shares outstanding: 25.12m
- Website: https://www.papoutsanis.gr
Number of Employees
Location
- Papoutsanis S.A.
- 71st Km National Road
- Athens - Lamia
- Chalkida
- 34100
- Greece
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| PAP | ATSE (The Athens Stock Exchange) | Yes | Common Shares | GR | EUR | Jul 1993 |
Biography
Papoutsanis S.A. produces and sells body, face, and hair care products in Greece and internationally. The company offers facial and bar soaps, shampoos, shower gels, body lotions, hand creams, hand washes, ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/08/24 20:49 |
| End of Day Share Price | 2019/08/23 00:00 |
| Earnings | 2018/12/31 |
| Annual Earnings | 2018/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.